RUNX1 and acute myeloid leukemia: BPDCN-like cases with mutated RUNX1 should be considered very carefully as far as RUNX1 mutations are the most common somatic alterations in pDC-AML (> 70%) and much more common than in AML without pDC expansion and BPDCN [58, 59].